Last reviewed · How we verify
use of fentanyl patch that was halved
use of fentanyl patch that was halved is a Small molecule drug developed by Meir Medical Center. It is currently in Phase 1 development.
At a glance
| Generic name | use of fentanyl patch that was halved |
|---|---|
| Sponsor | Meir Medical Center |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- use of fentanyl patch that was halved CI brief — competitive landscape report
- use of fentanyl patch that was halved updates RSS · CI watch RSS
- Meir Medical Center portfolio CI
Frequently asked questions about use of fentanyl patch that was halved
What is use of fentanyl patch that was halved?
use of fentanyl patch that was halved is a Small molecule drug developed by Meir Medical Center.
Who makes use of fentanyl patch that was halved?
use of fentanyl patch that was halved is developed by Meir Medical Center (see full Meir Medical Center pipeline at /company/meir-medical-center).
What development phase is use of fentanyl patch that was halved in?
use of fentanyl patch that was halved is in Phase 1.